RECORDATI ACQUIRES RIGHTS TO ASTRAZENECA'S METOPROLOL BASED TREATMENTS IN EUROPE
Milan, 22 May 2017 - Recordati announced that it has entered into an agreement with AstraZeneca for the acquisition of the rights to Seloken®/Seloken® ZOK (metoprolol succinate) and associated Logimax® fixed dose combination (metoprolol succinate and …